Company West Pharmaceutical Services, Inc.
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 248.95 USD | +7.48% |
|
+7.71% | -9.52% |
| 05/02 | West Pharmaceutical Services, Inc. - Special Call | |
| 03/02 | Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $320 From $390 | MT |
Business description: West Pharmaceutical Services, Inc.
- proprietary products (80.7%);
- - contract-manufactured products (19.3%).
At the end of 2024, the group had 21 production sites worldwide.
Net sales are distributed geographically as follows: the United States (42.5%), Germany (12.9%), Ireland (11.2%), France (8.4%), Europe (13.3%) and other (11.7%).
Number of employees: 10,600
Sales by Activity: West Pharmaceutical Services, Inc.
| Fiscal Period: December | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) |
|---|---|---|---|---|---|
Proprietary Products | 164.86Cr | 231.73Cr | 240.68Cr | 239.73Cr | 233.45Cr |
Contract-Manufactured Products | 50Cr | 51Cr | 48Cr | 55Cr | 56Cr |
Corporate and Unallocated | -3L | -4L | -3L | - | - |
Geographical breakdown of sales: West Pharmaceutical Services, Inc.
| Fiscal Period: December | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) |
|---|---|---|---|---|---|
United States | 98Cr | 119.8Cr | 128.65Cr | 123.85Cr | 123.08Cr |
Other European Countries | 24Cr | 34Cr | 36Cr | 39Cr | 39Cr |
Germany | 28Cr | 47Cr | 40Cr | 41Cr | 37Cr |
Other | 25Cr | 36Cr | 36Cr | 35Cr | 34Cr |
Ireland | 23Cr | 25Cr | 24Cr | 29Cr | 32Cr |
France | 17Cr | 21Cr | 24Cr | 28Cr | 24Cr |
Executive Committee: West Pharmaceutical Services, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Green
CEO | Chief Executive Officer | 56 | 24/04/2015 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 04/08/2025 |
Quintin Lai
IRC | Investor Relations Contact | 59 | 11/01/2016 |
Chad Winters
AUD | Comptroller/Controller/Auditor | 47 | 01/10/2019 |
Annette Favorite
HRO | Human Resources Officer | 61 | 05/10/2015 |
Composition of the Board of Directors: West Pharmaceutical Services, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Hofmann
BRD | Director/Board Member | 74 | 16/10/2007 |
Mark Buthman
BRD | Director/Board Member | 65 | 01/02/2011 |
Douglas Michels
BRD | Director/Board Member | 69 | 07/03/2011 |
William Feehery
BRD | Director/Board Member | 56 | 12/02/2012 |
Myla Lai-Goldman
BRD | Director/Board Member | 68 | 17/02/2014 |
Eric Green
CHM | Chairman | 56 | 24/05/2022 |
Paolo Pucci
BRD | Director/Board Member | 65 | 12/09/2016 |
Deborah Keller
BRD | Director/Board Member | 63 | 01/06/2017 |
Robert Friel
BRD | Director/Board Member | 70 | 17/02/2020 |
Molly Joseph
BRD | Director/Board Member | 52 | 19/08/2021 |
Company details: West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc.
530 Herman O. West Drive
19341-1147, Exton
+610 594 2900
http://www.westpharma.com
Group companies: West Pharmaceutical Services, Inc.
| Name | Category and Sector |
|---|---|
West Pharmaceutical Packaging India Pvt Ltd.
 West Pharmaceutical Packaging India Pvt Ltd. Part of West Pharmaceutical Services, Inc., West Pharmaceutical Packaging India Pvt Ltd. is an Indian company that provides high-quality vial containment solutions for pharmaceuticals. The company was founded in 2008 and is based in Hyderabad, India. The company offers reliable and innovative designs for drug packaging needs, including novapure® stoppers and west flurotec® plungers that improve the shelf life of packaged drugs and reduce particulates to enhance the compatibility between closure and drug for better performance. Pharmaceutical, biotechnology, generic, and medical device companies trust West and their ability to deliver consistent high-quality and technologically advanced containment and delivery solutions. | |
TGPR Holdings Ltd.
 TGPR Holdings Ltd. Part of West Pharmaceutical Services, Inc., TGPR Holdings Ltd. is an Irish company. The company is located in Ireland. | |
West Pharmaceutical Services Holding GmbH
 West Pharmaceutical Services Holding GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products |
Pharmaceuticals: Major
|
West Pharmaceutical Services Holding GmbH
West Pharmaceutical Services Holding GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products |
Pharmaceuticals: Major
|
West Pharmaceutical Services Singapore Pte Ltd.
 West Pharmaceutical Services Singapore Pte Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs |
Pharmaceuticals: Major
|
Other Medical Equipment, Supplies & Distribution
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.48% | +7.71% | -22.58% | -6.08% | 1.79TCr | |
| +1.60% | +1.40% | -14.13% | +0.57% | 19TCr | |
| -0.05% | -0.06% | +14.32% | +19.43% | 13TCr | |
| +2.01% | +0.01% | +44.93% | +127.59% | 6.99TCr | |
| +1.70% | +3.21% | -8.63% | -16.07% | 5.98TCr | |
| +3.55% | +6.08% | +44.06% | +94.56% | 5.69TCr | |
| +2.38% | +7.01% | - | - | 3.94TCr | |
| +0.11% | -4.20% | -20.56% | -36.30% | 2.73TCr | |
| +3.42% | -3.98% | +12.96% | +16.82% | 2.47TCr | |
| -0.17% | -5.15% | -16.15% | -48.36% | 2.04TCr | |
| Average | +2.07% | +0.78% | +3.80% | +16.91% | 6.41TCr | |
| Weighted average by Cap. | +1.41% | +1.04% | +5.52% | +23.83% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- WST Stock
- Company West Pharmaceutical Services, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition